Skip to main content

Advertisement

Log in

Aspergillus hubkae, a Novel Species Isolated from a Patient with Probable Invasive Pulmonary Aspergillosis

  • Original Article
  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

A 50-year-old man, previously diagnosed with pulmonary tuberculosis and lung cavities, presented with symptoms including fever, shortness of breath, and cough. A pulmonary CT scan revealed multiple cavities, consolidation and tree-in-bud in the upper lungs. Further investigation through direct examination of bronchoalveolar lavage fluid showed septate hyphae with dichotomous acute branching. Subsequent isolation and morphological analysis identified the fungus as belonging to Aspergillus section Nigri. The patient was diagnosed with probable invasive pulmonary aspergillosis and successfully treated with a three-month oral voriconazole therapy. Phylogenetic analysis based on partial β-tubulin, calmodulin and RNA polymerase second largest subunit sequences revealed that the isolate represents a putative new species related to Aspergillus brasiliensis, and is named Aspergillus hubkae here. Antifungal susceptibility testing demonstrated that the isolate is resistant to itraconazole but susceptible to voriconazole. This phenotypic and genetic characterization of A. hubkae, along with the associated case report, will serve as a valuable resource for future diagnoses of infections caused by this species. It will also contribute to more precise and effective patient management strategies in similar clinical scenarios.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Cadena J, Thompson GR, Patterson TF. Aspergillosis: epidemiology, diagnosis, and treatment. Infect Dis Clin North Am. 2021;35(2):415–34.

    Article  PubMed  Google Scholar 

  2. Kanaujia R, Singh S, Rudramurthy SM. Aspergillosis: an update on clinical spectrum, diagnostic schemes, and management. Curr Fungal Infect Rep. 2023. https://doi.org/10.1007/s12281-023-00461-5.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Stemler J, Többen C, Lass-Flörl C, et al. Diagnosis and treatment of invasive aspergillosis caused by non-fumigatus aspergillus spp. J Fungi. 2023;9(4):500.

    Article  CAS  Google Scholar 

  4. Mosseray R. Les Aspergillus de la section “Niger” Thom & Church. Cellule. 1934;43:203–85.

    Google Scholar 

  5. Raper KB, Fennell DI. The genus Aspergillus. Philadelphia: Williams & Wilkins; 1965.

    Google Scholar 

  6. Al-Musallam A. Revision of the black Aspergillus species [dissertation]. Utrecht: Utrecht University; 1980.

    Google Scholar 

  7. Samson RA, Houbraken J, Kuijpers AF, Frank JM, Frisvad JC. New ochratoxin A or sclerotium producing species in Aspergillus section Nigri. Stud Mycol. 2004;50(1):45–56.

    Google Scholar 

  8. Perrone G, Stea G, Epifani F, Varga J, Frisvad JC, Samson RA. Aspergillus niger contains the cryptic phylogenetic species A. awamori. Fungal Biol. 2011;115(11):1138–50.

    Article  CAS  PubMed  Google Scholar 

  9. Hong SB, Lee M, Kim DH, et al. Aspergillus luchuensis, an industrially important black Aspergillus in East Asia. PLoS ONE. 2013;8(5): e63769.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Varga J, Frisvad JC, Kocsubé S, et al. New and revisited species in Aspergillus section Nigri. Stud Mycol. 2011;69(1):1–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Houbraken J, Kocsubé S, Visagie CM, et al. Classification of Aspergillus, Penicillium, Talaromyces and related genera (Eurotiales): an overview of families, genera, subgenera, sections, series and species. Stud Mycol. 2020;95:5–169.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Silva JJD, Iamanaka BT, Ferranti LS, et al. Diversity within Aspergillus niger clade and description of a new species: Aspergillus vinaceus sp. nov. J Fungi. 2020;6(4):371.

    Article  Google Scholar 

  13. Khuna S, Suwannarach N, Kumla J, et al. Growth enhancement of arabidopsis (Arabidopsis thaliana) and onion (Allium cepa) with inoculation of three newly identified mineral-solubilizing fungi in the genus Aspergillus section Nigri. Front Microbiol. 2021;12: 705896.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Bian C, Kusuya Y, Sklenář F, et al. Reducing the number of accepted species in Aspergillus series Nigri. Stud Mycol. 2022;102:95–132.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. 3rd ed. CLSI standard M38 (ISBN 1–56238–830–4 [Print]; ISBN 1–56238–831–2 [Electronic]). Wayne: Clinical and Laboratory Standards Institute; 2017.

  16. Glass NL, Donaldson GC. Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomycetes. Appl Environ Microbiol. 1995;61(4):1323–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Hong SB, Cho HS, Shin HD, Frisvad JC, Samson RA. Novel Neosartorya species isolated from soil in Korea. Int J Syst Evol Microbiol. 2006;56(Pt 2):477–86.

    Article  CAS  PubMed  Google Scholar 

  18. de Hoog GS, van den Ende AH. Molecular diagnostics of clinical strains of filamentous Basidiomycetes. Mycoses. 1998;41(5–6):183–9.

    Article  PubMed  Google Scholar 

  19. Masclaux F, Guého E, de Hoog GS, Christen R. Phylogenetic relationships of human-pathogenic Cladosporium (Xylohypha) species inferred from partial LS rRNA sequences. J Med Vet Mycol. 1995;33(5):327–38.

    Article  CAS  PubMed  Google Scholar 

  20. Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30(4):772–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Vaidya G, Lohman DJ, Meier R. SequenceMatrix: concatenation software for the fast assembly of multi-gene datasets with character set and codon information. Cladistics. 2011;27(2):171–80.

    Article  PubMed  Google Scholar 

  22. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014;30(9):1312–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Nylander, JAA. 2004. MrModeltest v2. Program distributed by the author. Uppsala: Evolutionary Biology Centre, Uppsala University; 2004.

  24. Ronquist F, Teslenko M, van der Mark P, et al. MrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a large model space. Syst Biol. 2012;61(3):539–42.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015;70(3):270–7.

    Article  PubMed  Google Scholar 

  26. Li L, Jiang Z, Shao C. Pulmonary Aspergillus overlap syndromes. Mycopathologia. 2018;183(2):431–8.

    Article  PubMed  Google Scholar 

  27. Roboubi A, Audousset C, Fréalle É, et al. Allergic bronchopulmonary aspergillosis: a multidisciplinary review. J Mycol Med. 2023;33(3): 101392.

    Article  PubMed  Google Scholar 

  28. Kanj A, Abdallah N, Soubani AO. The spectrum of pulmonary aspergillosis. Respir Med. 2018;141:121–31.

    Article  PubMed  Google Scholar 

  29. Zarif A, Thomas A, Vayro A. Chronic pulmonary aspergillosis: a brief review. Yale J Biol Med. 2021;94(4):673–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Lamoth F, Calandra T. Pulmonary aspergillosis: diagnosis and treatment. Eur Respir Rev. 2022;31(166): 220114.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367–76.

    Article  PubMed  Google Scholar 

  32. Patterson TF, Thompson GR III, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1–60.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Maertens JA, Raad II, Marr KA, et al. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet. 2016;387(10020):760–9.

    Article  CAS  PubMed  Google Scholar 

  34. Maertens JA, Rahav G, Lee DG, et al. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Lancet. 2021;397(10273):499–509.

    Article  CAS  PubMed  Google Scholar 

  35. Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl 1):e1–38.

    Article  PubMed  Google Scholar 

  36. Aruanno M, Glampedakis E, Lamoth F. Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside. Antimicrob Agents Chemother. 2019;63(8):e00399-e419.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Vermeulen E, Maertens J, Meersseman P, Saegeman V, Dupont L, Lagrou K. Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital. Clin Microbiol Infect. 2014;20(5):O333–5.

    Article  CAS  PubMed  Google Scholar 

  38. Nargesi S, Jafarzadeh J, Najafzadeh MJ, et al. Molecular identification and antifungal susceptibility of clinically relevant and cryptic species of Aspergillus sections Flavi and Nigri. J Med Microbiol. 2022;71(4): 001480.

    Article  CAS  Google Scholar 

  39. Najafzadeh MJ, Dolatabadi S, Zarrinfar H, Houbraken J. Molecular diversity of Aspergilli in two Iranian hospitals. Mycopathologia. 2021;186(4):519–33.

    Article  PubMed  Google Scholar 

  40. Manikandan P, Varga J, Kocsubé S, et al. Keratitis caused by the recently described new species Aspergillus brasiliensis: two case reports. J Med Case Rep. 2010;4:68.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Sabino R, Veríssimo C, Parada H, et al. Molecular screening of 246 Portuguese Aspergillus isolates among different clinical and environmental sources. Med Mycol. 2014;52(5):519–29.

    Article  CAS  PubMed  Google Scholar 

  42. Mehta M, Sharma J, Bhardwaj SB. Proximal subungual onychomycosis of digitus minimus due to Aspergillus brasiliensis. Pan Afr Med J. 2020;35:79.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Öz Y, Özdemir HG, Gökbolat E, Kiraz N, Ilkit M, Seyedmousavi S. Time-kill kinetics and in vitro antifungal susceptibility of non-fumigatus Aspergillus species isolated from patients with ocular mycoses. Mycopathologia. 2016;181(3–4):225–33.

    Article  PubMed  Google Scholar 

  44. Raksha, Singh G, Urhekar AD. Virulence factors detection in Aspergillus isolates from clinical and environmental samples. J Clin Diagn Res. 2017;11(7):DC13–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Howard SJ, Harrison E, Bowyer P, Varga J, Denning DW. Cryptic species and azole resistance in the Aspergillus niger complex. Antimicrob Agents Chemother. 2011;55(10):4802–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Samson RA, Visagie CM, Houbraken J, et al. Phylogeny, identification and nomenclature of the genus Aspergillus. Stud Mycol. 2014;78:141–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

None to declare.

Funding

This work was supported by the China Scholarship Council (202208110069).

Author information

Authors and Affiliations

Authors

Contributions

YBZ completed molecular experiments, phylogenetic analyses, and drafted the manuscript. JH designed all the experiments and revised the manuscript. BGE and FH conducted the antifungal susceptibility testing and edited the manuscript. MM and BK helped with the DNA isolation and sequencing. ARM contributed to collection of the strain, case description and reviewing the manuscript. SA contributed to treatment and follow-up of the patient. NK contributed to follow-up of the patient and case description. AT and AHN contributed to case data curation. All authors have read and approved the final manuscript for publication.

Corresponding author

Correspondence to Jos Houbraken.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Ethical Approval

Not applicable.

Consent to Participate

Written informed consent was obtained from the patient.

Consent to Publish

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Additional information

Handling Editor: Macit Ilkit.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, Y.B., Rezaei-Matehkolaei, A., Meijer, M. et al. Aspergillus hubkae, a Novel Species Isolated from a Patient with Probable Invasive Pulmonary Aspergillosis. Mycopathologia 189, 44 (2024). https://doi.org/10.1007/s11046-024-00848-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11046-024-00848-z

Keywords

Navigation